The Scientist

» biobusiness

Most Recent

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

image: SEC Charges Theranos With Fraud

SEC Charges Theranos With Fraud

By Jim Daley | March 14, 2018

The company raised more than $700 million based on false claims to investors, according to the complaint.

0 Comments

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

0 Comments

image: Accessing Drugs for Medical Aid-in-Dying

Accessing Drugs for Medical Aid-in-Dying

By Catherine Offord | August 17, 2017

A fraught market for the barbiturates prescribed to terminally ill patients who choose to end their lives has physicians turning to options outside big pharma.

0 Comments

image: Learning from Iceland’s Model for Genetic Research

Learning from Iceland’s Model for Genetic Research

By Catherine Offord | June 1, 2017

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

1 Comment

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By Kerry Grens | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By Kerry Grens | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By Jenny Rood | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

image: Abbott Acquires Diagnostics Firm

Abbott Acquires Diagnostics Firm

By Kerry Grens | February 2, 2016

In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.

0 Comments

image: TS Picks: CRISPR Patent Edition

TS Picks: CRISPR Patent Edition

By Kerry Grens | January 5, 2016

A challenge to the first CRISPR patent just got teeth.

3 Comments

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. RNA Moves a Memory From One Snail to Another
  3. Could a Dose of Sunshine Make You Smarter?
  4. Sweden Cancels Agreement With Elsevier Over Open Access